These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2563571)

  • 1. The possible role of new beta-adrenoceptor agonists in the treatment of obesity.
    Meinders AE
    Neth J Med; 1989 Feb; 34(1-2):1-2. PubMed ID: 2563571
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute effect of L-796568, a novel beta 3-adrenergic receptor agonist, on energy expenditure in obese men.
    van Baak MA; Hul GB; Toubro S; Astrup A; Gottesdiener KM; DeSmet M; Saris WH
    Clin Pharmacol Ther; 2002 Apr; 71(4):272-9. PubMed ID: 11956510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperplasia of brown adipose tissue after chronic stimulation of beta 3-adrenergic receptor in rats.
    Nagase I; Sasaki N; Tsukazaki K; Yoshida T; Morimatsu M; Saito M
    Jpn J Vet Res; 1994 Dec; 42(3-4):137-45. PubMed ID: 7745877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Better antiobesity drugs: coming--but when?
    Zoler ML
    Geriatrics; 1984 Jul; 39(7):126-8. PubMed ID: 6735181
    [No Abstract]   [Full Text] [Related]  

  • 5. New approaches to the control of obesity in animals and their clinical potential.
    Stock MJ
    Bibl Nutr Dieta; 1989; (44):32-7. PubMed ID: 2571330
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drugs and obesity: current status, prospects for the future].
    Apfelbaum M
    Rev Prat; 1984 Dec; 34(55):3121-4. PubMed ID: 6505592
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sibutramine, an upcoming drug for weight loss acting on energy consumption and energy expenditure].
    Astrup A
    Acta Med Austriaca; 1998; 25(4-5):146-9. PubMed ID: 9879391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of a beta-2 adrenoceptor (ADRB2) gene variant with a blunted in vivo lipolysis and fat oxidation.
    Jocken JW; Blaak EE; Schiffelers S; Arner P; van Baak MA; Saris WH
    Int J Obes (Lond); 2007 May; 31(5):813-9. PubMed ID: 17130852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta(3)-Adrenoceptor agonists: potential, pitfalls and progress.
    Arch JR
    Eur J Pharmacol; 2002 Apr; 440(2-3):99-107. PubMed ID: 12007528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the adrenergic beta 3-agonist, BRL37344, on heat production by brown adipocytes in obese and in older rats.
    Yamakawa A; Tanaka E; Nakano S
    Tokai J Exp Clin Med; 1994 Dec; 19(3-6):139-42. PubMed ID: 7570685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy of obesity: an update.
    Schurgin S; Siegel RD
    Nutr Clin Care; 2003; 6(1):27-37. PubMed ID: 12841428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug strategies for the treatment of obesity.
    Alemany M; Remesar X; Fernández-López JA
    IDrugs; 2003 Jun; 6(6):566-72. PubMed ID: 12811679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Obesity: current biochemical and therapeutic aspects].
    Ducobu J; Hainaut J; Liénart F; Dupont P
    Rev Med Brux; 1987 Feb; 8(2):67-76. PubMed ID: 3563185
    [No Abstract]   [Full Text] [Related]  

  • 14. [Beta-3 adrenergic receptor--structure and role in obesity and metabolic disorders].
    Wiejak J; Wyroba E
    Postepy Hig Med Dosw; 1999; 53(5):705-15. PubMed ID: 10645145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological treatment of obesity: therapeutic strategies.
    Kordik CP; Reitz AB
    J Med Chem; 1999 Jan; 42(2):181-201. PubMed ID: 9925722
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacologic treatment of obesity].
    Villanueva L; Carruba MO; Peñalva A; Pandiella A; Díaz Y; Casanueva FF; Cabezas Cerrato J; Fernández-Cruz A
    Rev Clin Esp; 1986 Oct; 179(6):317-22. PubMed ID: 3797737
    [No Abstract]   [Full Text] [Related]  

  • 17. The obese patient.
    Bray GA
    Major Probl Intern Med; 1976; 9():1-450. PubMed ID: 778504
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug information for nurses. Obesity; therapeutic main group: anorexictics, appetite depressants; 1].
    Lumholtz IB
    Sygeplejersken; 1976 Sep; 76(36):13. PubMed ID: 1050099
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial.
    Halford JC
    Curr Drug Targets; 2005 Mar; 6(2):143-4. PubMed ID: 15777184
    [No Abstract]   [Full Text] [Related]  

  • 20. Amylin may offer (more) help to treat postmenopausal obesity.
    Lutz TA
    Endocrinology; 2011 Jan; 152(1):1-3. PubMed ID: 21183707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.